These compounds may interact with:
Glutamate receptor ionotropic, NMDA 1
Potentially involved in: intellectual disability; carcinoma; schizophrenia; epilepsy; high pressure neurological syndrome; encephalitis; amblyopia; toxic encephalopathy; lingual-facial-buccal dyskinesia; alcoholic intoxication, chronic; bipolar disorder; hyperalgesia; mental retardation; pain; psychotic disorders; trigeminal neuralgia; cocaine-related disorders; low intelligence; mental deficiency; poor school performance
Disease data sourced from Pharos.